Abstract
The O-N intramolecular acyl migration, also named as an acyl shift or acyl transfer reaction, is well-known in organic and peptide chemistry as a simple rearrangement which proceeds under very mild aqueous conditions. Despite a long history with this reaction, its application in medicinal chemistry has only lately been proposed. In the last decade, this reaction has been intensively studied and several applications of this rearrangement in medicinal chemistry have appeared. O-N Intramolecular acyl migration has been employed in “no auxiliary, no byproduct” prodrug strategies (prodrugs of paclitaxel and other taxoids, prodrugs of HIV protease inhibitors), for the synthesis of peptides containing difficult sequences via “O-acyl isopeptide method”, including Alzheimers disease related amyloid β peptide (Aβ) 1-42, and in the design of pH-, photo- or enzyme-triggered click peptides, as a potential powerful tool for identifying the pathological functions of amyloid β peptides in Alzheimers disease. This review summarized recent advances in the application of O-N intramolecular acyl migration with special focus on medicinal chemistry.
Keywords: O-N Intramolecular acyl migration, O-N intramolecular acyl shift, O-N intramolecular acyl transfer, HIV protease inhibitor prodrugs, paclitaxel prodrugs, O-acyl isopeptide method, depsipeptide, Alzheimer's disease
Current Medicinal Chemistry
Title: Application of the O-N Intramolecular Acyl Migration Reaction in Medicinal Chemistry
Volume: 14 Issue: 26
Author(s): Mariusz Skwarczynski and Yoshiaki Kiso
Affiliation:
Keywords: O-N Intramolecular acyl migration, O-N intramolecular acyl shift, O-N intramolecular acyl transfer, HIV protease inhibitor prodrugs, paclitaxel prodrugs, O-acyl isopeptide method, depsipeptide, Alzheimer's disease
Abstract: The O-N intramolecular acyl migration, also named as an acyl shift or acyl transfer reaction, is well-known in organic and peptide chemistry as a simple rearrangement which proceeds under very mild aqueous conditions. Despite a long history with this reaction, its application in medicinal chemistry has only lately been proposed. In the last decade, this reaction has been intensively studied and several applications of this rearrangement in medicinal chemistry have appeared. O-N Intramolecular acyl migration has been employed in “no auxiliary, no byproduct” prodrug strategies (prodrugs of paclitaxel and other taxoids, prodrugs of HIV protease inhibitors), for the synthesis of peptides containing difficult sequences via “O-acyl isopeptide method”, including Alzheimers disease related amyloid β peptide (Aβ) 1-42, and in the design of pH-, photo- or enzyme-triggered click peptides, as a potential powerful tool for identifying the pathological functions of amyloid β peptides in Alzheimers disease. This review summarized recent advances in the application of O-N intramolecular acyl migration with special focus on medicinal chemistry.
Export Options
About this article
Cite this article as:
Skwarczynski Mariusz and Kiso Yoshiaki, Application of the O-N Intramolecular Acyl Migration Reaction in Medicinal Chemistry, Current Medicinal Chemistry 2007; 14 (26) . https://dx.doi.org/10.2174/092986707782360123
DOI https://dx.doi.org/10.2174/092986707782360123 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Secondary Brain Injuries in Thalamus and Hippocampus after Focal Ischemia Caused by Mild, Transient Extradural Compression of the Somatosensori Cortex in the Rat
Current Neurovascular Research Editorial (Thematic Issue: Neurobiological and Neurocognitive Basis of the Effects of Cannabinoids in Animals and Man: Therapeutic Potential of Cannabinoids in Psychiatry)
Current Pharmaceutical Design Genetic and Epigenetic Alterations in Pancreatic Carcinogenesis
Current Genomics SAR, QSAR and Docking of Anticancer Flavonoids and Variants: A Review
Current Topics in Medicinal Chemistry A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects
Current Neuropharmacology Influence of Betaine- and Choline-based Eutectic Solvents on Lipase Activity
Current Biochemical Engineering (Discontinued) Leukocyte Influx in Atherosclerosis
Current Drug Targets Intervention of Proliferation and Differentiation of Endogenous Neural Stem Cells in the Neurodegenerative Process of Huntingtons Disease Phenotype
CNS & Neurological Disorders - Drug Targets Comparative Account of Quality Management and Regulatory Aspects of Products with Health Claims: Existing Approaches and Future Challenges for Probiotics and Herbal Products
Applied Clinical Research, Clinical Trials and Regulatory Affairs Intracellular Signaling of the Aging Suppressor Protein Klotho
Current Molecular Medicine Defining the Mechanism of Action of 4-Phenylbutyrate to Develop a Small-Molecule-Based Therapy for Alzheimers Disease
Current Medicinal Chemistry The Role of Bacteria and Viruses in Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews Various Techniques for Measuring Physiological Parameters Using WSN: Current State of the Art and Challenges
International Journal of Sensors, Wireless Communications and Control Magnetite Polycitric Acid (Fe3O4@PCA) Nanoparticles: A Novel, Efficient and Reusable Solid Acid Catalyst for the Preparation of Polyhydroquinolines
Letters in Organic Chemistry Acetyl-L-Carnitine Modulates TP53 and IL10 Gene Expression Induced by 3-NPA Evoked Toxicity in PC12 Cells
Current Neuropharmacology Perspectives in Cell Cycle Regulation: Lessons from an Anoxic Vertebrate
Current Genomics Chelating Agents for the Sequestration of Mercury(II) and Monomethyl Mercury(II)
Current Medicinal Chemistry Withdrawal Notice: Comparison of Pharmaceutical Effect of Alemtuzumab and Natalizumab and Their Side Effects in Treatment of Various Stages of Multiple Sclerosis Patients
CNS & Neurological Disorders - Drug Targets Oxidative Phosphorylation as a Target to Arrest Malignant Neoplasias
Current Medicinal Chemistry Endocannabinoids and Their Receptors: Physiology, Pathology and Pharmacology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)